|
|
|
Investigation
|
Result
|
Unit
|
Normal Range
|
|
|
CBC
|
|
Total Count WBC
Blood/ Automated |
9400
|
Cells/cmm
|
4000 - 11000
|
|
Hemoglobin
Blood/ Automated |
15.2
|
g/dL
|
13.0 - 17.0
|
|
PCV
Blood/ Automated |
45.6
|
%
|
40 - 50
|
|
Platelets
Blood/ Automated |
2.96
|
thou cells/ ul
|
150 - 400
|
|
RBC Count
Blood/ Automated |
5.06
|
million/ul
|
4.5 - 5.5
|
|
MCV
Blood/ Automated |
84
|
fl
|
80 - 100
|
|
MCH
Blood/ Automated |
28
|
pg
|
27 - 32
|
|
MCHC
Blood/ Automated |
33
|
gm %
|
32 - 36
|
|
Neutrophils
Blood/ Automated |
49
|
%
|
40 - 65
|
|
Lymphocytes
Blood/ Automated |
46
|
%
|
30 - 50
|
|
Monocytes
Blood/ Automated |
02
|
%
|
02 - 04
|
|
Eosinophils
Blood/ Automated |
03
|
%
|
02 - 08
|
|
|
|
|
FREE T4,TSH
|
|
Free T4
CLIA |
1.16
|
ng/dL
|
0.7 - 1.48
|
|
TSH
Method: CLIA |
1.754
|
mIU/L
|
Adults : 0.35 - 5.1 Newborn - 4 Days : 1.0 - 38.9 Child - 14 Years : 1.0 - 9.1
Pregnancy Ranges::::,
Ist Tri :0.1 - 2.5,
IInd Tri :0.2 - 3.0,
IIIrd Tri:0.3 - 3.0,
|
|
|
|
|
Lipid Profile
|
|
Total Cholesterol
Method: Enzymatic/CHOD/PAP / SERUM |
250
|
mg/dl
|
Desirable : <200
Borderline high : 200 - 239
High : >239
|
|
TGL Triglyceride
Method: Glycerol-3-phosphate oxidase-PAP/ SERUM |
162
|
mg/dL
|
Less than 200 : desirable
200 - 400 :Normal Risk
More than 400 :High Risk
|
|
HDL High Density Lipoprotein
Method : Direct / SERUM |
62
|
mg/dL
|
Low :< 40
High :>=60
|
|
LDL Low Density Lipoprotein
Method : Homogenous Enzymatic colorimetric / Serum |
155.6
|
mg/dL
|
Optimal :<100
Near or above optimal : 100 - 129
Borderline high : 130 - 159
High : 160 - 189
Very high :>190
|
|
VLDL
Method : Calculation |
32.4
|
mg/dl
|
15 - 35 mg/dl
|
|
TOTAL CHO/HDL RATIO
Method : Calculation |
2.5
|
|
up to 5.0
|
|
|
|
|
Liver Function Test (LFT)
|
|
Total Bilirubin
|
0.48
|
mg/dL
|
|
|
Direct Bilirubin
Method: DSA / SERUM |
0.14
|
mg/dl
|
Up to 0.4
|
|
Indirect Bilirubin
Method : Calculation / SERUM |
0.34
|
|
|
|
SGPT (ALT)
Method: UV without pyridoxal phosphate / SERUM |
48
|
IU/L
|
Adult
Male :<45
Female:<34
|
|
SGOT (AST)
Method: UV without pyridoxal phosphate / SERUM |
27
|
U/L
|
Adult
Male :<35
Female:<31
|
|
Gamma Glutamyl transferase (GGT)
( Method: IFCC - Enzymatic Colorimetric / SERUM |
33
|
U/L
|
Up to 55 U/L
|
|
Alkaline Phosphotase
Method : P-NPP/IFCC / SERUM |
65
|
IU/L
|
Children : 180 - 341
(Age and gender dependent)
16 - 18 years 52 - 171
> 18 years 30 - 120
|
|
Total Protein
Method: Biuret / SERUM |
6.07
|
g/dl
|
Adult : 6.4 - 8.3
|
|
Albumin (serum)
Method: Bromocresol Green/ SERUM |
4.42
|
g/dL
|
Adult - 3.5 - 5.2
|
|
Globulin
Method : Calculation |
1.7
|
g/dl
|
2.6 - 4.1
|
|
A\G RATIO
Method : Calculation |
2.6
|
g/dl
|
1.5 - 3.3 g/dl
|
|
|
|
|
Other
|
|
BUN Blood Urea Nitrogen
Method : GLDH/Urease |
25
|
mg/dL
|
6 - 24
|
|
Creatinine
Method : Enzymatic / SERUM |
0.44
|
mg/dL
|
Cord : 0.6-1.2
Newborn
1-4 days : 0.3 - 1.0
Infant : 0.2 - 0.4
Child : 0.3 - 0.7
Adolescent: 0.5 - 1.0
Adult (18 - 60 years)
Male : 0.62 - 1.1
Female :0.45 - 0.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|